Drug Development Executive

Share this post

User's avatar
Drug Development Executive
Thalidomide's Lingering Shadow: Why True Protection for Pregnant Women Demands Their Inclusion in Clinical Trials

Thalidomide's Lingering Shadow: Why True Protection for Pregnant Women Demands Their Inclusion in Clinical Trials

Eswar Krishnan, MD's avatar
Eswar Krishnan, MD
May 21, 2025
∙ Paid

Share this post

User's avatar
Drug Development Executive
Thalidomide's Lingering Shadow: Why True Protection for Pregnant Women Demands Their Inclusion in Clinical Trials
Share

The word "thalidomide" casts a long, dark shadow over medical history. In the late 1950s and early 1960s, this seemingly innocuous drug, prescribed for morning sickness, led to an unimaginable tragedy: thousands of babies born with severe birth defects. The catastrophe seared into our collective consciousness the devastating consequences of inadequate d…

Keep reading with a 7-day free trial

Subscribe to Drug Development Executive to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Eswar Krishnan
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share